Dear Reader,3 powerful forces are about to converge fueling a bigger profit bonanza than this industry's EVER seen...
Investors who get in now could pocket $1,263,100 or more starting in the next few weeks...
'm
going to be very blunt.This could go down as one of the easiest years in recent memory to make an absolute killing in the stock market.
And when I say make a killing, I'm not talking about the standard 8%-12% that stockbrokers quote you. No, I'm talking about something much, much bigger...
But this coming superboom won't apply to the market as a whole. And it won't even happen to every stock in the sector I'm about to tell you about.
No, the biggest gains will come to a tiny group of stocks that stand to benefit from an unusual set of circumstances that comes around once every decade or so.
And please know that it's going to happen with or without you, so the only question you need to ask yourself is,
"Am I ready, right now, to ride one of the greatest trends of my lifetime to extraordinary riches?"
If you answered 'yes' to this question then I believe you have what it takes to make this the year that changes your life... forever!
You could have the opportunity to quit your job, travel the world, take care of your family, and secure your retirement. That's how big this is...
Or you could sit on the sidelines and watch it happen for other people. The choice is yours...
But if you're still with me, let's dive right into this unbelievable situation...
Let me get right to the heart of this opportunity...
"Certain stocks in the biotechnology sector are on the verge of skyrocketing thousands of percent in what could be one of the greatest surges we've seen in the last 20 years!"
Customers who are in desperate need of your products (in many cases their very lives depend on it).
Now imagine that technology is making your products better than they have ever been before- pushing your profit margins through the roof.
And finally, imagine that the government is about to pass a bill giving you exclusive rights to make and sell your product nearly 2 1/2 times longer than your competitors get!
Any one of these conditions could make you a mint...
But take all of them together, and you have a recipe for some serious wealth creation. The kind of wealth creation that could last for generations...
And if you look closely enough, you'll see that the wheels have already started turning on this amazing opportunity...
It's true.
In March of 2009, I began looking at a stock that was trading at just 45 cents a share.
This stock was a former high-flier named Human Genome Sciences (HGSI).
Human Genome's story is a lot like other small biotechnology company's. They spend all their time and money developing drugs that cure or treat disease.
And when these drugs successfully pass through the FDA approval process, fortunes can be made overnight!
And that's exactly what happened with this stock.
You see HGSI has a drug for lupus, a serious autoimmune disease that affects the skin, joints, kidneys, and other organs...
Called Benlysta, this drug promises to be a lifesaver for those who suffer from this dreadful disease.
And while it appears to be very effective, it does cost between $15,000 and $30,000 per year!
Now if you consider that there are hundreds of thousands of cases of Lupus in the United States alone-- well, you can see the potential.
And so can investors...
Once Benlysta started showing positive results in clinical trials throughout 2009, the stock absolutely took off. Take a look for yourself...
When it was all said and done, HGSI rocketed from $0.45 a share to $30.98. That's a 6,784% gain... in less than 9 months.
To put that kind of return in perspective, if you had invested about $15,000 into this one stock, you'd be sitting on a million dollar bank account less than a year later!
Even if you had invested less, you'd still be doing pretty well. For example:
- $250 turns into $17,210
- $500 turns into $34,420
- $1,750 turns into $120,470
- $4,000 turns into $275,360
In fact, three once-in-a-lifetime catalysts are converging at this very moment that could set off a virtual stampede into these stocks!
Here's why...
Biotech companies make money by providing cures and treatments to illness and disease. And guess which segment of the population is most susceptible to illness and disease?
You guessed it- those over the age of 50.
And guess which segment of the population is growing the fastest?
Right again, those over the age of 50.
You see all those Baby Boomers born between 1946 and 1962 are getting older. In fact, over 10,000 boomers a day become for social security!
| "A strong combination of technological advance and
the aging of the American baby boom generation -- has created a once-in-a-lifetime opportunity." -San Francisco Chronicle |
As an example of what this could mean for investors, take the case of Vermillion (VRMLQ).
Right now Vermillion is working on a number of 'interesting' products.
One in particular helps identify Peripheral Artery Disease. An estimated 12 million people have this condition and it's recommended that everyone over the age of 50 test for it.
As this product moved through the FDA pipeline in 2009, the stock soared from about $0.01 a share to a peak of $20.25 (and that took just 3 months)!
Now to get that kind of return you'd need to have some really good timing. But can you imagine capturing just a fraction of that?
You can now see why I'm such a big fan of these stocks!
And as the market for these products grows because of the aging population, you'll see more and more profit opportunities like Vermillion. More and more chances to take a small sum... and turn it into a verifiable fortune!
It's like a giant tidal wave has been set in motion...
... and those who are ready to ride it will reap unimaginable profits.
So let's quickly move on...
Further fueling the biotech boom will be the incredible advances that are being made in technology. Some of these things sound like they come from science fiction movies...
| “Biotechnology is
revolutionizing medicine in ways that were unimaginable just a
few years ago...” - Alan Greenspan |
And based on what's coming down the FDA pipeline, this could be a watershed year for amazing new treatments...
Take Power 3 Medical (PWRM) for example.
This company uses proteomics to detect diseases far earlier than the tests being used now. Imagine if you could detect a disease like Alzheimer's or breast cancer one, two, or even FIVE years earlier than is now possible .
I don't have to tell you how that would improve treatment and boost survival rates!
With millions of people affected by these diseases, you can see the tremendous potential of this arm of biotechnology.
Another company, AVAX Technologies (AVXT) has a Stage 3 drug named MVax that may one day treat late-stage melanoma.
The amazing thing is, the vaccine comes from the actual tumor inside the patient! This company pulls out the cells, modifies them, and then injects them back in the body.
Needless to say, these are some amazing technologies. And investors have noticed...
Power 3 Medical soared 1,980% and AVAX Technologies skyrocketed 1,712% towards the end of 2009. That's nearly a 20-fold increase in your initial investment in each stock!
Try getting those returns with boring old blue chips! It just isn't going to happen...
And I haven't even told you the best reason why you must get into biotech stocks RIGHT NOW!
I know. I know.
You’re sick and tired of hearing about all the fighting over 'ObamaCare' or The Patient Protection and Affordable Care Act (PPACA) as its known in Washington.
| “Provisions in the health care bill would not allow generic imitators of biotech drugs on the market until after the original drugs have been on sale for 12 years.” - Boston Globe |
Why you ask?
Because it grants a special ‘gift’ to biotech companies.
A gift that virtually guarantees watershed profits for biotech companies for many years to come…
So what is it?
Now that might not mean a whole lot to you now- but it should.
You see, most conventional drugmakers get 5 years of patent protection for any new drugs they develop. After 5 years, generic versions of the drug are made and the price (and profits) plunge.
But not for biotech companies...
Under the new law, they get a full 12 years until generics can be made. That’s an extra 7 years of blockbuster profits…
Think about that.
Pfizer (a conventional drugmaker) gets a new drug approved and gets 5 years until generics are made and the price of the drug plummets. Amgen (or any other biotech) gets a new drug approved and gets nearly 2 ½ times longer…
I’m not exaggerating when I tell you this is a major turning point for the biotech industry. And one you can take all the way to the bank.
The law is serving as a turbo-booster for biotech firms that get FDA approval for new drugs and treatments. It definitely raises the stakes...
So instead of seeing a biotech stock jump 100%-200% as they move through the FDA clinical trial process, we could start seeing 1,000%-5,000% gains instead!
Think about what that could do to your portfolio, your bank account… and your life.
It’s no secret that the biotech sector is setting itself up to deliver huge gains in the months ahead. The three catalysts I just told you about have opened a major window of opportunity...
I’m talking about the chance to see 100%, 500%, even 1,000%+ gains in just the weeks or months ahead.
For those who are still unsure you should know that this coming avalanche has already begun. Just take a look at these moves…
And these are just a few examples (believe me there were many, many more!)Titan Pharmaceuticals (TTNP) jumped 11,900% in 10 months...
Starting with just a small bankroll, picks like these can add up to significant gains. In fact, if you'd put $5,000 into each of the 5 picks above, you'd have over ONE MILLION DOLLARS-- $1,263,100 to be exact!
And that doesn't include "rolling them over" or anything like that...
Not everyone has $5,000 to put into these stocks, and that's ok. Regardless of how much you have to invest, even if it's just a few hundred dollars, the potential returns you can get from these stocks are truly unbelievable!
And you’d be surprised how easy it is to enjoy these returns with even less risk than you probably accept right now trading blue chip stocks like General Electric and Intel.
With biotech you're looking at the fastest growing stocks in the world… At a time when demand is soaring and supply just can’t keep up...
You get stocks that can literally soar hundreds, even thousands of percent at the drop of a hat. You get the kind of stocks that can propel several thousand dollars into $1,263,100 or more!
And you can get it all handed to you on a silver platter…
Allow me to introduce myself. My name is Robert Morris. I work for one of the fastest growing investment research firms in the world.
One of the reasons I know so much about biotechnology is that I’m also the head of small cap research here at Hyperion Financial. That means I spend most of my day researching stocks that trade for less than $10 a share.
And guess what?
The majority of promising biotechs fall under $10 a share.
So over the years I’ve developed a special system specifically tailored to these stocks. And its helped subscribers to my other services make a heck of a lot of money!
Things have been so good in fact, that we decided it would really help people to have a service dedicated solely to biotech.
Which is exactly why I’m so excited about what’s happening in this amazing sector right now.
In the days ahead, I’ll show a handful of investors how they could overflow their accounts with triple- and quadruple-digit gains just like the ones mentioned above… All in the ultra-fast moving biotech sector… With stocks that are riding the crest of a massive tidal wave headed for the markets right now!
This is your chance to finally get ahead of the curve… and make more money than you ever thought possible!
For most investors, keeping tabs on the biotechnology field is difficult to say the least. And few investment research firms are willing to invest the time and resources to really dig deep into this profitable sector.
And you definitely won’t hear about these opportunities talked about on CNBC, MarketWatch or Cramer… until long after they’ve already made their big move.
For all these reasons and more, I’ve decided to team up with Hyperion Financial to launch a trading system to help you take full advantage of this historic avalanche of profits…
Called Biotech Supertrader, this unique investment service will identify small biotech stocks that are about to see their share prices skyrocket!
It could be a new product, it could be an FDA decision, it could be an acquisition target… this new service will look for them all- and give you all the information you need to profit.
Week after week, month after month, I will share with you the best opportunities to buy early stage positions in the world’s most promising biotech companies with just a click of the mouse or a quick call to your broker.
In addition, when you become a member of Biotech Supertrader, I will fulfill four crucial commitments to you:
I’ve worked hard and spent a great deal of money getting the resources in place to bring a service of this caliber to your front door.Commitment #1: To help you make as much money as you can while things are hot, I will send you only those stocks that have a real chance of giving you a 200% return or better…
And now my team is ready to get to work for you- in Biotech Supertrader: the ONLY investment trading service designed from the bottom-up to make you mountains of money from the coming biotech boom!
You can become a member of Biotech Supertrader today and start profiting from what could become one of the greatest moneymaking opportunities of your generation.
And to help you get ready for your first blockbuster trade, here’s what you’ll get as soon as you join:
Plus, if you join now, you’ll get 2 special reports designed to get you up-to-speed on the best way to squeeze every bit of profit out of your biotech trades:1-2 biotech stock recommendations every month. Each and every month, I’ll identify only those biotech companies that are about to have something major happen to their stock price. These are stocks that could return double, triple, or even 10 times your initial investment.
First, Biotechnology Investing 101 will get you up-to-speed on what it takes to make a killing in this sector. You’ll discover the basics of biotech stocks, how they work, when to buy and sell, and important pitfalls to watch out for. It’s all included in this informative guide... FREE and instantly available with your subscription.
Second, my Biotech Supertrader Operating Manual will lay out the exact system I use to regularly find blockbuster biotech trades that fill your pockets with cash. You’ll know exactly which stocks to buy, how long to hold them, and when it’s time to get out!
When you become a member of Biotech Supertrader, you’ll have everything you need to profit from this once-in-a-lifetime event right at your fingertips…
I made Biotech Supertrader so easy to use that anyone with an internet connection could start seeing eye-popping gains, almost immediately…
But you should know that not many individual investors get a chance to join a service like this. A service designed to identify a trend, make its members a fortune from it, and then tell 'em when to get out.
Here’s the thing though – the cost to join a research service this precise can be prohibitive to many investors…
In fact, many investors put up a seven-figure deposit or better to get in on one of the investment pools set-up by brokerage houses to get this kind of “specialized” intelligence…
Venture capitalists and institutional investors are willing to pay 5-figure ‘consulting’ fees just to get a clue as to where these stocks are heading…
Yet right now the price for this trading service has been set at just $4,000 per year.
Which is a bargain considering what just one of my recommendations can do to your bank account. I wouldn’t be surprised to see one of your first few picks pay for an entire year of service, and then some. That’s real money you can take to the bank.
But I’ve got great news for you. I’ve made special arrangements with my publisher to make this available at a special price. There's only one problem...
Because of the sensitive nature of this research, we can’t give access to it to every Tom, Dick, and Harry investor. If we do, we’ll have too many people chasing the exact same stocks...
… which would only serve to artificially inflate the prices of the stocks I recommend. That means some subscribers wouldn't be able to establish their positions at reasonable levels.
And considering the importance of this mega-trend, that’s just not something I want to happen.
So we’ve decided to limit the initial number of subscribers to Biotech Supertrader to just 750. I thought we could take a few more but my publisher said no.
But as a concession, they did agree to lower the price- temporarily.
So, for a very limited time, you can get Biotech Supertrader for the bargain basement price of just $197 per quarter.
Now, I don’t know how long this will last. Given the magnitude of this opportunity, and what’s already happening in the market, I don’t see it lasting very long…
But if you take advantage of this situation now, you’re guaranteed that price (and a spot) for life. That means you get all the trade alerts, special reports, position updates, sell signals, sector briefings and more at this special rate forever…
And the quarterly billing cycle means no long-term commitments....
So take a deep breath, you’re about to tap into what’s likely to become the biggest bull market in modern history…
I’m going to make this very simple.
Join Biotech Supertrader right now.
Read the special reports I’ve prepared for you. Paper trade a few recommendations. And take a couple of months to think it over.
If at any time during the first 90 days you’re not completely satisfied, just let me know and we'll cancel your subscription at the end of the quarter.
That way you only pay for the time you use...
Any profits you’ve made, the special reports, the recommendations, the position and sector updates- they’re all yours to keep.
But remember...
Imagine investing in companies that steadily return 152%, 3,314%, 6,566%, or even 11,900% like clockwork.
We’ve said it before and we’ll say it again: with biotech stocks, it’s not only possible, it’s probable!
And every time I identify one of these biotech gems, you’ll receive an instant alert via email. It’ll give you everything you need to know – exactly what to buy, ticker symbol, how to order, and most importantly, when to sell for maximum profit.
You don’t need any special skills… there are no numbers to crunch or moving averages to follow. Just simple, straightforward recommendations anyone can take advantage of.
But let me be clear about one thing. Time is of the essence. Every time a biotech stock goes through the roof and you’re not on board, it’s money out of your pocket.
So click here to secure your spot right away in Biotech Supertrader.
Either way, it's time for YOU to join in on the biotech profit party!
YES! I want to profit from what may be the biggest biotech bull market of the last 20 years!
 Add To Cart  Question? email us at customerservice@hyperionfinancial.com |
Sincerely,
Robert Morris
Editor, Biotech Supertrader
P.S. Right now, forces have aligned that signal the beginning of an immense bull market in biotech stocks. The coming biotech superboom will send many stocks up 100%, 1,000%, even 5,000% or more! And you won't have to wait years and years to see these results. Join Biotech Supertrader now to cash in on this once-in-a-lifetime opportunity...
Click the subscribe button right now to join and receive your first recommendations!
Contact Us | About Us | Terms of Use | Privacy Policy | FAQ